◀ Back to MAPK3

GNAI1 — MAPK3

Pathways - manually collected, often from reviews:

• OpenBEL Selventa BEL large corpus: MAPK3 → GNAI1 (increases, GNAI1 Activity, MAPK3 Activity) Viedt et al., Arterioscler Thromb Vasc Biol 2002*
  Evidence: Stimulation of VSMCs with MCP-1 induced proliferation and resulted in a concentration- and time-dependent release of the proinflammatory cytokine interleukin-6 (IL-6). MCP-1 also induced extracellular signal-regulated kinase, which, along with IL-6 release, was inhibited by pertussis toxin.
• NCI Pathway Database S1P1 pathway: Erk1-2 (MAPK3/MAPK1) → S1P1/S1P/Gi complex (S1PR1-GNAI2_GNAI3_GNAO1_GNAO1_GNAZ_GNAI1) (modification, collaborate)
  Van Brocklyn et al., Cancer Lett 2002
  Evidence: mutant phenotype, assay
• NCI Pathway Database S1P1 pathway: S1P1/S1P/Gi complex (S1PR1-GNAI2_GNAI3_GNAO1_GNAO1_GNAZ_GNAI1) → Erk1-2-active (MAPK3/MAPK1) (modification, activates)
  Van Brocklyn et al., Cancer Lett 2002
  Evidence: mutant phenotype, assay
• NCI Pathway Database S1P4 pathway: Erk1-2 (MAPK3/MAPK1) → S1P/S1P4/Gi complex (S1PR4-GNAI2_GNAI3_GNAO1_GNAO1_GNAZ_GNAI1) (modification, collaborate)
  Van Brocklyn et al., J Biol Chem 1999
  Evidence: mutant phenotype, assay
• NCI Pathway Database S1P3 pathway: Erk1-2 (MAPK3/MAPK1) → S1P/S1P3/Gi complex (S1PR3-GNAI2_GNAI3_GNAO1_GNAO1_GNAZ_GNAI1) (modification, collaborate)
  Baudhuin et al., FASEB J 2004
  Evidence: mutant phenotype, assay
• NCI Pathway Database S1P2 pathway: Erk1-2 (MAPK3/MAPK1) → S1P/S1P2/Gi complex (S1PR2-GNAI2_GNAI3_GNAO1_GNAO1_GNAZ_GNAI1) (modification, collaborate)
  An et al., J Biol Chem 2000, Arikawa et al., J Biol Chem 2003, Gonda et al., Biochem J 1999
  Evidence: mutant phenotype, assay
• WikiPathways Signal Transduction of S1P Receptor: GNAI1/GNAI2/GNAI3 → MAPK3/MAPK1/MAPK6/MAPK4/MAPK7/MAPK12 (activation)